Oculocerebrorenal syndrome: Difference between revisions

Jump to navigation Jump to search
← Older edit
VisualWikitext
Aarti Narayan (talk | contribs)
nocaptcha
7,243 edits
No edit summary
Irfan Dotani (talk | contribs)
nocaptcha, smwadministrator, Administrators
3,478 edits
No edit summary
 
(6 intermediate revisions by one other user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{CMG}}; {{AE}} {{AN}}
{{SK}} Lowe's syndrome
{{Infobox_Disease |
{{Infobox_Disease |
   Name          = {{PAGENAME}} |
   Name          = {{PAGENAME}} |
Line 10: Line 14:
   OMIM          = 309000 |
   OMIM          = 309000 |
   MedlinePlus    = |
   MedlinePlus    = |
   eMedicineSubj  = oph |
   eMedicineSubj  = |
   eMedicineTopic = 516 |
   eMedicineTopic = |
   MeshID        = D009800 |
   MeshID        = D009800 |
}}
}}
{{CMG}}; {{AE}} {{AN}}


==Overview==
==Overview==
'''Oculocerebrorenal syndrome''' (also called '''Lowe syndrome''') is a [[X-linked]] recessive disorder characterized by [[hydrophthalmia]], [[cataract]]s, [[mental retardation]], [[aminoaciduria]], reduced renal [[ammonia]] production and vitamin D-resistant [[rickets]].
'''Oculocerebrorenal syndrome''' is a [[X-linked]] recessive disorder characterized by [[hydrophthalmia]], [[cataract]]s, [[mental retardation]], [[aminoaciduria]], reduced renal [[ammonia]] production and vitamin D-resistant [[rickets]].


==Historical Perspective==
==Historical Perspective==
It is named for Charles Upton Lowe.<ref>{{WhoNamedIt|synd|3512}}</ref><ref>{{cite journal |author=Lowe CU, Terrey M, MacLachlan EA |title=Organic-aciduria, decreased renal ammonia production, hydrophthalmos, and mental retardation; a clinical entity |journal=A.M.A. American journal of diseases of children |volume=83 |issue=2 |pages=164-84 |year=1952 |pmid=14884753 |doi=}}</ref>
It is named after Charles Upton Lowe, who was the first to describe the condition.<ref>{{WhoNamedIt|synd|3512}}</ref><ref>{{cite journal |author=Lowe CU, Terrey M, MacLachlan EA |title=Organic-aciduria, decreased renal ammonia production, hydrophthalmos, and mental retardation; a clinical entity |journal=A.M.A. American journal of diseases of children |volume=83 |issue=2 |pages=164-84 |year=1952 |pmid=14884753 |doi=}}</ref>
 
==Classification==


==Pathophysiology==
==Pathophysiology==
Line 27: Line 32:
===Genetics===
===Genetics===
It is associated with [[mutation]] in the [[gene]] [[OCRL]].
It is associated with [[mutation]] in the [[gene]] [[OCRL]].
==Causes==


==Differentiating Oculocerebrorenal syndrome from other diseases==
==Differentiating Oculocerebrorenal syndrome from other diseases==
Line 39: Line 46:
*As the disease follows an [[X-linked]] inheritance pattern, almost all affected patients are males. However, a few females with this condition have been reported.
*As the disease follows an [[X-linked]] inheritance pattern, almost all affected patients are males. However, a few females with this condition have been reported.


==Complications==
==Risk Factors==
 
==Screening==
 
==Natural History, Complications, and Prognosis==
*[[Muscle tone]] improves with age, but never comes back to normal.
*[[Muscle tone]] improves with age, but never comes back to normal.
*[[Scoliosis]]
*[[Scoliosis]]
Line 50: Line 61:


==Diagnosis==
==Diagnosis==
===History===
===History and Symptoms===
*[[Mental retardation]]
*[[Mental retardation]]
*[[Seizures]]
*[[Seizures]]
*[[Febrile seizures]]
*[[Febrile seizure]]s
*Behavioral disturbances
*Behavioral disturbances
**Temper tantrums
**Temper tantrums
Line 59: Line 70:
**Unusual repetitive movements
**Unusual repetitive movements
**[[Irritability]]
**[[Irritability]]
**[[Rigidity]]
**[[Muscle rigidity|Rigidity]]
**Preoccupations and obsessions
**Preoccupations and obsessions
*[[Constipation]]
*[[Constipation]]
Line 70: Line 81:


====Skin====
====Skin====
*cysts
*[[Cyst]]s


==== Eyes ====
====Eyes====
*Decreased [[visual acuity]]
*Decreased [[visual acuity]]
*[[Cataract]] at birth
*[[Cataract]] at birth
Line 79: Line 90:
*[[Strabismus]]
*[[Strabismus]]


==== Extremities ====
====Extremities====
*[[Joint swelling]]: small and large joints
*[[Joint swelling]]: small and large joints
*[[Arthritis]]
*[[Arthritis]]
*[[Tenosynovitis]]
*[[Tenosynovitis]]
*Joint [[contractures]]
*Joint contractures


==== Neurologic ====
====Neurologic====
*Generalized neonatal [[hypotonia]]
*Generalized neonatal [[hypotonia]]
*[[Areflexia]]
*[[Areflexia]]
Line 92: Line 103:
*[[Delayed milestones]]
*[[Delayed milestones]]


==== Other ====
====Other====
*[[Cryptorchidism]]
*[[Cryptorchidism]]
*Skin and mucosal cysts
*Skin and mucosal cysts
*Delayed dentition
*Delayed dentition
*Dental caries
*[[Dental caries]]
*Gingival inflammation
*Gingival inflammation
*Dental cysts
*Dental cysts


=== Laboratory Findings ===  
===Laboratory Findings===
====Urinalysis====
*Low [[osmolarity]]
*[[Albuminuria]]
*Low molecular weight [[proteiuria]]: [[retinol binding protein]], [[β2 microglobulin]]
*[[Bicarbonate]] loss
*[[Aminoaciduria]]
*[[Hypercalciuria]]
*[[Hyperphosphaturia]]
*Decreased [[creatinine clearance]]
*L-carnitine lost in urine
 
====Blood Tests====
*Raised [[ESR]]
*High [[alkaline phosphatase]]
*Blood gases:
**Low [[bicarbonate]] levels
**Compensatory decrease in PCO2 levels
*Raised [[serum creatinine]] levels
*Serum markers: Rise in
**[[AST]]
**[[LDH]]
**[[Creatinine kinase]]
*[[Acid phosphatase]]
*[[T4]], [[TSH]] levels increased
====Other tests====
*Measurement of enzyme activity in cultured [[fibroblasts]] is the preferred test for establishing diagnosis.
===X ray===
*[[Osteopenia]]
*Metaphyseal [[flarring]] and [[cupping]]
===MRI===
*[[Demyelination]] of [[white matter]] in the [[periventricular area]]
===Ultrasonography===
*[[Nephrocalcinosis]]
*[[Nephrolithiasis]]
 
==Treatment==
===Ocular===
*[[Glaucoma]]:
**Patients should be monitored for [[glaucoma]]
**Intraocular pressure lowering agents
**Surgery: [[Glaucoma surgery|trabeculotomy]], [[Glaucoma surgery|drainage filtration device]]
*Corneal keloids:
**Topical steroids, lubricants
**Lamellar keratectomy, corneal transplant
*[[Strabismus]] and [[refraction error]]s must be corrected.
*[[Catarct]]s should be surgically removed, preferably in the first 6 months of life, to prevent development of [[amblyopia]]. Aphakic correction must follow the surgery.


===Renal function===
*Must be monitored to look for development of [[Chronic renal failure|renal failure]], tubular wasting
*[[Blood pH]] and electrolytes should be followed up.
===Neurologic symptoms===
*[[Seizure]]s should be treated with appropriate [[anticonvulsant]]s.
===Diet===
*[[Phosphate]] supplements
*[[Carnitine]] replacement
*[[Vitamin D]] supplementation
===Behavioral therapy===
*Behavioral modification for maladaptive behavioral patterns
===Others===
*[[Speech therapy]] and [[occupational therapy]] may be initiated as needed.
===Prevention===
   
   
==References==
==References==
<references/>
{{reflist|2}}
 
==External Links==
*[http://www.lowesyndrome.org/ Lowe Syndrome Association Official Website]
*[http://www.lowetrust.com/ U.K. Lowe Syndrome Trust]


{{Metabolic pathology}}
{{Metabolic pathology}}
{{SIB}}
[[fr:Syndrome de Lowe]]
[[de:Lowe-Syndrom]]
[[fi:Lowen oireyhtymä]]
[[pl:Zespół Lowe'a]]
[[Category:Inborn errors of metabolism]]


[[Category:Endocrinology]]


{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}

Latest revision as of 19:28, 21 July 2016

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]

Synonyms and keywords: Lowe's syndrome

Oculocerebrorenal syndrome
ICD-10 E72.0
ICD-9 270.8
OMIM 309000
DiseasesDB 29146
MeSH D009800

Overview

Oculocerebrorenal syndrome is a X-linked recessive disorder characterized by hydrophthalmia, cataracts, mental retardation, aminoaciduria, reduced renal ammonia production and vitamin D-resistant rickets.

Historical Perspective

It is named after Charles Upton Lowe, who was the first to describe the condition.[1][2]

Classification

Pathophysiology

  • Mutation in the OCRL gene leads to membrane defects which results in inability of proximal tubular cells to reabsorb low molecular weight proteins, bicarbonates and phosphorus.
  • There is impaired intra-cellular protein folding and sorting, especially in polarized cells like renal epithelium and optic lens. This explains the pathogenesis of renal dysfunction and cataract.

Genetics

It is associated with mutation in the gene OCRL.

Causes

Differentiating Oculocerebrorenal syndrome from other diseases

Differential diagnosis

Epidemiology and Demographics

  • Oculocerebrorenal syndrome is a rare disease with a prevalence of about 1 in 200,000 to 1 in every 500,000 births.

Sex

  • As the disease follows an X-linked inheritance pattern, almost all affected patients are males. However, a few females with this condition have been reported.

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Appearance of the Patient

Skin

Eyes

Extremities

Neurologic

Other

Laboratory Findings

Urinalysis

Blood Tests

Other tests

  • Measurement of enzyme activity in cultured fibroblasts is the preferred test for establishing diagnosis.

X ray

MRI

Ultrasonography

Treatment

Ocular

Renal function

  • Must be monitored to look for development of renal failure, tubular wasting
  • Blood pH and electrolytes should be followed up.

Neurologic symptoms

Diet

Behavioral therapy

  • Behavioral modification for maladaptive behavioral patterns

Others

Prevention

References

  1. ↑ Template:WhoNamedIt
  2. ↑ Lowe CU, Terrey M, MacLachlan EA (1952). "Organic-aciduria, decreased renal ammonia production, hydrophthalmos, and mental retardation; a clinical entity". A.M.A. American journal of diseases of children. 83 (2): 164–84. PMID 14884753.

Template:Metabolic pathology


Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Oculocerebrorenal_syndrome&oldid=1244224"